Latest news
Loading news…
Mwyngil Therapeutics develops oral small-molecule therapies for metabolic, inflammatory, neuroinflammatory, and renal diseases.
Mwyngil Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Artificial Intelligence (AI)BiopharmaBiotechnologyHealth CareMachine LearningMedicalNeurosciencePharmaceuticalTherapeutics
Funding Rounds
1
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About Mwyngil Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Company Info
- Org types
- company
- HQ
- San Diego, California, United States
Mwyngil Therapeutics Funding Rounds
1 results
Upgrade to Pro to view this datasetUpgrade
| Organization Name | Funding Type | Lead Investor Names | Org Hq Country | ||
|---|---|---|---|---|---|
1–1 of 1Show
Page 1 / 1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Mwyngil Therapeutics
Loading news…
FAQs about Mwyngil Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.